Text Size A A A

Sun Pharma receives approval from DCGI to initiate clinical trial with Nafamostat in Covid 19 patients

Tell a Friend Print Home » Sun Pharma receives approval from DCGI to initiate clinical trial with Nafamostat in Covid 19 patients